Current Ratio of Immunome Inc. from 30 Jun 2021 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Immunome Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2021 to 31 Dec 2025.
- Immunome Inc. Current Ratio for the quarter ending 31 Dec 2025 was 11.85x, a 83% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Immunome Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 11.85x | +5.38x | +83% | 31 Dec 2025 |
| Q3 2025 | 7.9x | +0.43x | +5.8% | 30 Sep 2025 |
| Q2 2025 | 7.23x | +0.01x | +0.2% | 30 Jun 2025 |
| Q1 2025 | 6.52x | +0.75x | +13% | 31 Mar 2025 |
| Q4 2024 | 6.46x | +3.11x | +93% | 31 Dec 2024 |
| Q3 2024 | 7.47x | +5.02x | +205% | 30 Sep 2024 |
| Q2 2024 | 7.21x | +5.12x | +245% | 30 Jun 2024 |
| Q1 2024 | 5.77x | +2.94x | +104% | 31 Mar 2024 |
| Q4 2023 | 3.35x | -0.76x | -19% | 31 Dec 2023 |
| Q3 2023 | 2.45x | -2.34x | -49% | 30 Sep 2023 |
| Q2 2023 | 2.09x | -3.54x | -63% | 30 Jun 2023 |
| Q1 2023 | 2.82x | -4.56x | -62% | 31 Mar 2023 |
| Q4 2022 | 4.11x | -4.56x | -53% | 31 Dec 2022 |
| Q3 2022 | 4.79x | -6.22x | -56% | 30 Sep 2022 |
| Q2 2022 | 5.63x | -3.7x | -40% | 30 Jun 2022 |
| Q1 2022 | 7.39x | 31 Mar 2022 | ||
| Q4 2021 | 8.67x | 31 Dec 2021 | ||
| Q3 2021 | 11.01x | 30 Sep 2021 | ||
| Q2 2021 | 9.33x | 30 Jun 2021 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.